Valentina Tateo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Advanced Non Small Cell Lung Cancer

Acute Lymphoblastic Leukemia

Top Venues

Pharmaceuticals (Basel, Switzerland)

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Cigliola, Alina Basnet, Joseph M Jacob, Chiara Mercinelli, Valentina Tateo, Damiano Alfio Patanè, Gennady Bratslavsky, Liang Cheng, Petros D Grivas, Ashish M Kamat, Philippe E Spiess, Dean C Pavlick, Douglas I Lin, Jeffery S Ross, Andrea Necchi
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study. JCO precision oncology 8 (2024)
Chiara Mercinelli, Marco Moschini, Antonio Cigliola, Benedetta Mattorre, Valentina Tateo, Giuseppe Basile, Laura L Cogrossi, Brigida Anna Maiorano, Damiano A Patanè, Daniele Raggi, Giovanni L Pastorino, Chiara Re, Maurizio Colecchia, Roberta Lucianò, Renzo Colombo, Giorgio Brembilla, Francesco De Cobelli, Alberto Briganti, Dean C Pavlick, Jeffery S Ross, Francesco Montorsi, Maria Teresa Sabrina Bertilaccio, Andrea Necchi
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Valentina Tateo, Paola Valeria Marchese, Veronica Mollica, Francesco Massari, Razelle Kurzrock, Jacob J Adashek
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Mirta Mosca, Nicole Conci, Alessandro Di Federico, Valentina Tateo, Valentina Favorito, Arianna Zappi, Francesco Gelsomino, Andrea De Giglio
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis. JCO precision oncology 7 (2023)
Valentina Tateo, Paola Valeria Marchese, Veronica Mollica, Francesco Massari, Razelle Kurzrock, Jacob J Adashek
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Costantino Ricci, Francesca Ambrosi, Tania Franceschini, Francesca Giunchi, Giorgia Di Filippo, Eugenia Franchini, Francesco Massari, Veronica Mollica, Valentina Tateo, Federico Mineo Bianchi, Maurizio Colecchia, Andres Martin Acosta, Michelangelo Fiorentino
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type. Histopathology (2023)
Costantino Ricci, Francesca Ambrosi, Tania Franceschini, Francesca Giunchi, Alessia Grillini, Eugenia Franchini, Marco Grillini, Riccardo Schiavina, Francesco Massari, Veronica Mollica, Valentina Tateo, Federico Mineo Bianchi, Lorenzo Bianchi, Matteo Droghetti, Thais Maloberti, Giovanni Tallini, Maurizio Colecchia, Andres Martin Acosta, João Lobo, Kiril Trpkov, Michelangelo Fiorentino, Dario de Biase
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT. Virchows Archiv : an international journal of pathology (2023)
Valentina Tateo, Paola Valeria Marchese, Veronica Mollica, Francesco Massari, Razelle Kurzrock, Jacob J Adashek
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Valentina Tateo, Paola Valeria Marchese, Veronica Mollica, Francesco Massari, Razelle Kurzrock, Jacob J Adashek
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Valentina Tateo, Lisa Manuzzi, Claudia Parisi, Andrea De Giglio, Davide Campana, Maria Abbondanza Pantaleo, Giuseppe Lamberti
An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Valentina Tateo, Lisa Manuzzi, Andrea De Giglio, Claudia Parisi, Giuseppe Lamberti, Davide Campana, Maria Abbondanza Pantaleo
Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors. International journal of molecular sciences 21 (23) (2020)